Genexine Inc. - Net Worth and Insider Trading

Genexine Inc. Net Worth

The estimated net worth of Genexine Inc. is at least $451 Million dollars as of 2024-12-26. Genexine Inc. is the 10% Owner of Rezolute Inc and owns about 91,300,933 shares of Rezolute Inc (RZLT) stock worth over $451 Million. Details can be seen in Genexine Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Genexine Inc. has not made any transactions after 2019-07-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Genexine Inc.

To

Genexine Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Genexine Inc. owns 1 companies in total, including Rezolute Inc (RZLT) .

Click here to see the complete history of Genexine Inc.’s form 4 insider trades.

Insider Ownership Summary of Genexine Inc.

Ticker Comapny Transaction Date Type of Owner
RZLT Rezolute Inc 2019-07-23 10 percent owner

Genexine Inc. Latest Holdings Summary

Genexine Inc. currently owns a total of 1 stock. Genexine Inc. owns 91,300,933 shares of Rezolute Inc (RZLT) as of July 23, 2019, with a value of $451 Million.

Latest Holdings of Genexine Inc.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RZLT Rezolute Inc 2019-07-23 91,300,933 4.94 451,026,609

Holding Weightings of Genexine Inc.


Genexine Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Genexine Inc. has made a total of 0 transactions in Rezolute Inc (RZLT) over the past 5 years. The most-recent trade in Rezolute Inc is the acquisition of 34,482,758 shares on July 23, 2019, which cost Genexine Inc. around $10 Million.

Insider Trading History of Genexine Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Genexine Inc. Trading Performance

GuruFocus tracks the stock performance after each of Genexine Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Genexine Inc. is -68.18%. GuruFocus also compares Genexine Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Genexine Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Genexine Inc.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Genexine Inc.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -33.03 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -27.76 LIMIT LIMIT LIMIT LIMIT LIMIT

Genexine Inc. Ownership Network

Ownership Network List of Genexine Inc.

No Data

Ownership Network Relation of Genexine Inc.

Insider Network Chart

Genexine Inc. Owned Company Details

What does Rezolute Inc do?

Who are the key executives at Rezolute Inc?

Genexine Inc. is the 10 percent owner of Rezolute Inc. Other key executives at Rezolute Inc include Chief Medical Officer Brian Kenneth Roberts , director & 10 percent owner & Chief Executive Officer Nevan C Elam , and 10 percent owner Handok, Inc. .

Rezolute Inc (RZLT) Insider Trades Summary

Over the past 18 months, Genexine Inc. made no insider transaction in Rezolute Inc (RZLT). Other recent insider transactions involving Rezolute Inc (RZLT) include a net purchase of 46,600 shares made by Brian Kenneth Roberts , a net purchase of 183,351 shares made by Daron Evans , and a net purchase of 9,074 shares made by Wladimir Hogenhuis .

In summary, during the past 3 months, insiders sold 0 shares of Rezolute Inc (RZLT) in total and bought 19,000 shares, with a net purchase of 19,000 shares. During the past 18 months, 0 shares of Rezolute Inc (RZLT) were sold and 359,475 shares were bought by its insiders, resulting in a net purchase of 359,475 shares.

Rezolute Inc (RZLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rezolute Inc Insider Transactions

No Available Data

Genexine Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Genexine Inc.. You might contact Genexine Inc. via mailing address: 700 Daewangpangyo-ro, Korea Parkbldg. B, Bundang-gu, Seongnam-si, Gyeonggi-do M5 13488.

Discussions on Genexine Inc.

No discussions yet.